• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内分泌紊乱与肝功能障碍之间的相互作用:损伤机制与治疗方法

Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches.

作者信息

Vargas-Beltran Andres M, Armendariz-Pineda Samantha M, Martínez-Sánchez Froylan D, Martinez-Perez Carolina, Torre Aldo, Cordova-Gallardo Jacqueline

机构信息

Department of Hepatology, General Hospital Dr. Manuel Gea Gonzalez, Mexico City 14080, Mexico.

Faculty of Medicine, Meritorious Autonomous University of Puebla, Puebla 72420, Mexico.

出版信息

World J Gastroenterol. 2025 Aug 28;31(32):108827. doi: 10.3748/wjg.v31.i32.108827.

DOI:10.3748/wjg.v31.i32.108827
PMID:40900772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12400232/
Abstract

Endocrine disorders frequently lead to metabolic disturbances that significantly affect liver function. Understanding the complex interplay between hormonal imbalances and liver dysfunction is essential for advancing targeted therapeutic strategies. This comprehensive review explores the pathophysiological mechanisms linking major endocrine disorders to liver disease, with a focus on the roles of the thyroid, parathyroid, pancreas, adrenal glands, and sex hormones. Thyroid dysfunction is associated with alterations in liver enzyme levels and metabolic regulation, often resulting in hepatic steatosis or cholestasis. Hyperparathyroidism and consequent hypercalcemia have been linked to hepatic calcifications. Insulin resistance, both hepatic and peripheral, contributes to excessive lipid accumulation in the liver, exacerbating steatotic changes. Adrenal gland disorders, particularly in the setting of chronic liver disease, impair cortisol metabolism and may worsen hepatic injury. Additionally, sex hormones such as estrogen and testosterone modulate the progression of liver fibrosis and influence the development of metabolic syndrome. The intricate relationship between endocrine and hepatic systems underscores the need for a multidisciplinary approach in the management of liver disease. Addressing underlying hormonal disturbances may enhance patient outcomes and prevent further hepatic deterioration. Future research should prioritize integrative therapeutic strategies that concurrently target endocrine and liver dysfunction.

摘要

内分泌紊乱常常导致显著影响肝功能的代谢紊乱。了解激素失衡与肝功能障碍之间的复杂相互作用对于推进靶向治疗策略至关重要。这篇全面综述探讨了将主要内分泌紊乱与肝脏疾病联系起来的病理生理机制,重点关注甲状腺、甲状旁腺、胰腺、肾上腺和性激素的作用。甲状腺功能障碍与肝酶水平和代谢调节的改变有关,常导致肝脂肪变性或胆汁淤积。甲状旁腺功能亢进及随之而来的高钙血症与肝脏钙化有关。肝脏和外周的胰岛素抵抗会导致肝脏中脂质过度积累,加剧脂肪变性变化。肾上腺疾病,特别是在慢性肝病背景下,会损害皮质醇代谢并可能加重肝损伤。此外,雌激素和睾酮等性激素会调节肝纤维化的进展并影响代谢综合征的发展。内分泌系统与肝脏系统之间的复杂关系强调了在肝病管理中采用多学科方法的必要性。解决潜在的激素紊乱问题可能会改善患者预后并防止肝脏进一步恶化。未来的研究应优先考虑同时针对内分泌和肝功能障碍的综合治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/d07bf16c3d82/wjg-31-32-108827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/519393a81e9d/wjg-31-32-108827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/289037a41661/wjg-31-32-108827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/aac8eb1b2255/wjg-31-32-108827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/5ffcf8d5ee21/wjg-31-32-108827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/d07bf16c3d82/wjg-31-32-108827-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/519393a81e9d/wjg-31-32-108827-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/289037a41661/wjg-31-32-108827-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/aac8eb1b2255/wjg-31-32-108827-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/5ffcf8d5ee21/wjg-31-32-108827-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b738/12400232/d07bf16c3d82/wjg-31-32-108827-g005.jpg

相似文献

1
Interplay between endocrine disorders and liver dysfunction: Mechanisms of damage and therapeutic approaches.内分泌紊乱与肝功能障碍之间的相互作用:损伤机制与治疗方法
World J Gastroenterol. 2025 Aug 28;31(32):108827. doi: 10.3748/wjg.v31.i32.108827.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Nonalcoholic Fatty Liver非酒精性脂肪肝
4
Steatotic liver disease arising in an asymptomatic 20-year-old man with panhypopituitarism and elevated transaminases.一名20岁无症状男性,患有全垂体功能减退症且转氨酶升高,出现了脂肪性肝病。
Can Liver J. 2024 Dec 19;7(4):511-516. doi: 10.3138/canlivj-2024-0030. eCollection 2024 Dec.
5
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病:肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
6
Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolism.内分泌疾病继发的糖尿病:意大利内分泌学会(SIE)营养激素与代谢俱乐部工作组的立场声明
J Endocrinol Invest. 2025 Apr 28. doi: 10.1007/s40618-025-02589-2.
7
Sex differences in endocrine, metabolic and psychological disturbance in obese patients with OSA.阻塞性睡眠呼吸暂停肥胖患者内分泌、代谢及心理紊乱的性别差异。
Biol Sex Differ. 2025 Jul 1;16(1):48. doi: 10.1186/s13293-025-00730-7.
8
Herbal mixture of Platycodon grandiflorum, Cinnamomum cassia, and Asiasarum sieboldii extracts protects against NASH progression via regulation of hepatic steatosis, inflammation, and apoptosis.桔梗、肉桂和细辛提取物的草药混合物通过调节肝脏脂肪变性、炎症和细胞凋亡来预防非酒精性脂肪性肝炎的进展。
Phytomedicine. 2025 Jul 14;145:157077. doi: 10.1016/j.phymed.2025.157077.
9
Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease.肝腐胺水平升高可能是与代谢功能障碍相关的脂肪性肝病进展的新潜在因素。
J Pathol. 2024 Sep;264(1):101-111. doi: 10.1002/path.6330. Epub 2024 Jul 18.
10
Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity.不当饮食通过腹部肥胖加剧代谢功能障碍相关脂肪性肝病。
Nutrients. 2024 Dec 5;16(23):4208. doi: 10.3390/nu16234208.

本文引用的文献

1
ACG Clinical Guideline: Malnutrition and Nutritional Recommendations in Liver Disease.美国胃肠病学会临床指南:肝病中的营养不良与营养建议
Am J Gastroenterol. 2025 May 1;120(5):950-972. doi: 10.14309/ajg.0000000000003379. Epub 2025 May 2.
2
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2025.4. 合并症的综合医学评估与评定:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S59-S85. doi: 10.2337/dc25-S004.
3
Exploring cytokines dynamics: Uncovering therapeutic concepts for metabolic disorders in postmenopausal women- diabetes, metabolic bone diseases, and non-alcohol fatty liver disease.
探索细胞因子动态:揭示绝经后妇女代谢紊乱的治疗概念-糖尿病、代谢性骨病和非酒精性脂肪肝疾病。
Ageing Res Rev. 2024 Nov;101:102505. doi: 10.1016/j.arr.2024.102505. Epub 2024 Sep 21.
4
Insulin-like growth factor-1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver-related mortality.肝硬化中的胰岛素样生长因子-1与肝功能障碍和纤维化相关,并可预测肝脏相关死亡率。
Aliment Pharmacol Ther. 2025 Jan;61(1):88-98. doi: 10.1111/apt.18289. Epub 2024 Sep 21.
5
Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach.丙硫氧嘧啶和甲巯咪唑致肝损伤风险的比较:一种定量系统毒理学方法。
Toxicol Appl Pharmacol. 2024 Oct;491:117064. doi: 10.1016/j.taap.2024.117064. Epub 2024 Aug 8.
6
Gut-Liver-Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies.健康与疾病中的肠-肝-胰轴相互作用:从微生物代谢产物的作用到创新的微生物群调控策略。
Biomedicines. 2024 Jun 24;12(7):1398. doi: 10.3390/biomedicines12071398.
7
Research advances in understanding crosstalk between organs and pancreatic β-cell dysfunction.器官间相互作用与胰腺β细胞功能障碍关系的研究进展
Diabetes Obes Metab. 2024 Oct;26(10):4147-4164. doi: 10.1111/dom.15787. Epub 2024 Jul 23.
8
Normoglycemia and physiological cortisone level maintain glucose homeostasis in a pancreas-liver microphysiological system.在胰腺-肝脏微生理系统中,正常血糖和生理皮质醇水平维持葡萄糖内稳态。
Commun Biol. 2024 Jul 18;7(1):877. doi: 10.1038/s42003-024-06514-w.
9
The role of adipose tissue dysfunction in hepatic insulin resistance and T2D.脂肪组织功能障碍在肝胰岛素抵抗和 T2D 中的作用。
J Endocrinol. 2024 Aug 2;262(3). doi: 10.1530/JOE-24-0115. Print 2024 Sep 1.
10
From liver to hormones: The endocrine consequences of cirrhosis.从肝脏到激素:肝硬化的内分泌后果。
World J Gastroenterol. 2024 Mar 7;30(9):1073-1095. doi: 10.3748/wjg.v30.i9.1073.